28. April 2015

http://www.cytec.com/company/news/press-release/cytec-showcasing-how-docusate-products-can-improve-apis’-solubility

04. March 2015

Poor bioavailability is a major reason for compounds to fail in preclinical development. Due to the complex nature of a multitude of existing as well as newly discovered active ingredients, solubility and bioavailability problems are inherent in the pharmaceutical industry causing major delays in drug development... See more at: http://drug-dev.com/Main/Back-Issues/SPECIAL-FEATURE-Bioavailability-Solubility-A-Deman-875.aspx#sthash.ah8PQxq2.dpuf